Issue 1074: September 4, 2013 TOP STORIES
IAC WEB SECTIONS IAC HANDOUTS
VACCINE INFORMATION STATEMENTS OFFICIAL RELEASES AND ANNOUNCEMENTS FEATURED RESOURCES EDUCATION AND TRAINING TOP STORIES New! September 2013 issue of Needle Tips now online The September issue of Needle Tips is now online.
This issue of Needle Tips presents information about IAC’s new campaign, Give birth to the end of Hep B, which gives birthing institutions the tools they need to establish, implement, and optimize a birth dose policy. As always, the issue features the "Ask the Experts" column from CDC medical officer Andrew T. Kroger, MD, MPH; nurse educator Donna L. Weaver, RN, MN; and medical officer Iyabode Akinsanya-Beysolow, MD, MPH. Back to top Dr. Anne Schuchat’s "Dear Colleague" letter urges healthcare professionals to discuss benefits of annual influenza vaccination with patients CDC recently posted a "Dear Colleague" letter written by Anne Schuchat, MD, director, National Center for Immunization and Respiratory Diseases. In the letter, Dr. Schuchat urges healthcare professionals to talk with patients and the parents of children about the benefits of yearly influenza vaccination—for people of all ages. The letter also encourages providers to begin vaccinating as soon as vaccine is available and to educate themselves about the influenza vaccine options currently available. Related Links
IAC Spotlight! Reminder to use IAC’s 27 new educational materials for patients and staff; 20 are available in Spanish translation IAC wants to remind you that during the past year we have created 27 new patient handouts and staff-education materials. Twenty of them are available in Spanish translation. Please review them to see if they might be of help to you in your work setting.
CDC publishes report on 2012 national and state vaccination coverage among adolescents age 13–17 CDC published National and State Vaccination Coverage Among Adolescents Aged 13–17 Years—United States, 2012 in the August 30 issue of MMWR (pages 685–693). The report includes information on vaccination coverage by age (Table 1); race, ethnicity, and poverty status (Table 2), and state and area (Table 3). The first paragraph of the article is reprinted below. At ages 11 through 12 years, the Advisory Committee on Immunization Practices (ACIP) recommends that preteens receive 1 dose of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, 1 dose of meningococcal conjugate (MenACWY) vaccine, and 3 doses of human papillomavirus (HPV) vaccine. ACIP recommends administration of all age-appropriate vaccines during a single visit. ACIP also recommends that pre-teens and older adolescents receive an annual influenza vaccine as well as any overdue vaccines (e.g., varicella). To monitor vaccination coverage among persons aged 13–17 years, CDC analyzed data from the National Immunization Survey–Teen (NIS-Teen). This report highlights findings of that analysis. From 2011 to 2012, coverage increased for ≥1 Tdap vaccine dose (from 78.2% to 84.6%), ≥1 MenACWY vaccine dose (from 70.5% to 74.0%) and, among males, ≥1 HPV vaccine dose (from 8.3% to 20.8%). Among females, vaccination coverage estimates for each HPV vaccine series dose were similar in 2012 compared with 2011. Coverage varied substantially among states. Regarding Healthy People 2020 targets for adolescents, 36 states achieved targets for Tdap, 12 for MenACWY, and nine for varicella vaccine coverage. Large and increasing coverage differences between Tdap and other vaccines recommended for adolescents indicate that substantial missed opportunities remain for vaccinating teens, especially against HPV infection. Health-care providers should administer recommended HPV and meningococcal vaccinations to boys and girls during the same visits when Tdap vaccine is given. In addition, whether for health problems or well-checks, providers, parents, and adolescents should use every health-care visit as an opportunity to review adolescents' immunization histories and ensure that every adolescent is fully vaccinated. Back to top Wild poliovirus detected in sewers in Israel; CDC posts clinical update on polio vaccine guidance for travelers The World Health Organization reported that as of August 15, wild poliovirus type 1 (WPV1) had been detected in 67 sewage samples taken from sites in Israel’s southern and central districts. WPV1 has also been isolated in stool samples from one adult and 27 healthy children (all younger than age nine) who had been fully immunized for their age. No polio cases have been identified.
IAC WEB SECTIONS IAC updates online Ask the Experts Q&A web sections on hepatitis B, rabies, and rotavirus Based on content review by vaccine experts at CDC, IAC recently updated the hepatitis B, rabies, and rotavirus sections of Ask the Experts. To access Ask the Experts sections for other vaccines and diseases, see the Ask the Experts index page. Back to top IAC HANDOUTS IAC updates four popular influenza staff resources: its two checklists for influenza vaccination contraindications and its two influenza standing orders templates IAC has updated the following influenza-related staff resources for the 2013–14 influenza vaccination season.
Back to top IAC updates its staff education materials "Current Dates of Vaccine Information Statements" and "It's Federal Law! You must give your patients current Vaccine Information Statements (VISs)" IAC recently revised Current Dates of Vaccine Information Statements (VISs) and It's Federal Law! You must give your patients current Vaccine Information Statements (VISs). Both now include the issue date of the most recent version of the VIS for rotavirus vaccine. CDC posted this VIS to its website on August 26. For information on the VIS for rotavirus vaccine, see the IAC Express article titled CDC releases updated rotavirus VIS, which was published on August 27. Related Links
IAC updates Q&As for the public on three vaccine-preventable diseases: hepatitis B, rabies, and rotavirus IAC recently revised the following three patient-and-parent handouts:
Dr. Ari Brown's "Clear Answers & Smart Advice About Your Baby's Shots" newly updated Written by pediatrician and author Ari Brown, MD, the 6-page handout Clear Answers & Smart Advice About Your Baby's Shots addresses the concerns of vaccine-hesitant parents. Dr. Brown recently revised the content of the question and answer about antifreeze in vaccines. Back to top VACCINE INFORMATION STATEMENTS IAC posts four additional influenza VIS translations IAC recently posted translations of both the inactivated influenza vaccine (IIV) VIS and the live attenuated influenza vaccine (LAIV) VIS in Ilokano, Marshallese, and Turkish. In addition, the VIS for IIV is available in Indonesian. IAC thanks the Hawaii State Department of Health for the Ilokano and Marshallese translations, Dr. Mustafa Kozanoglu for the Turkish translations, and DT Interpreting for the Indonesian translation. Related Links
OFFICIAL RELEASES AND ANNOUNCEMENTS American Academy of Pediatrics releases 2013–14 influenza policy statement On September 2, the American Academy of Pediatrics (AAP) published Policy Statement: Recommendations for Prevention and Control of Influenza in Children, 2013–2014 in the September issue of the journal Pediatrics. Highlights include details about vaccine strains for the 2013–2014 influenza season, newly licensed quadrivalent influenza vaccines with an additional B virus, annual universal influenza immunization with either a trivalent or quadrivalent vaccine (no preference), and the 2013–2014 dosing algorithm (unchanged from 2012–2013). Related Links
FEATURED RESOURCES Order IAC's popular full-size laminated versions of the 2013 U.S. immunization schedules today! IAC's laminated versions of the 2013 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".
PRICING 1–4 copies: $7.50 each 5–19 copies: $5.50 each 20-99 copies: $4.50 each 100–499 copies: $4.00 each 500–999 copies: $3.50 each For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page. Back to top EDUCATION AND TRAINING October 28–30 Nevada Health Conference includes CDC's Epidemiology & Prevention of Vaccine-Preventable Diseases course The 2013 Nevada Health Conference will be held October 28–30 in Henderson, NV. The conference will include presentations by regional and national experts on chronic disease prevention, health promotion, and maternal, child, and adolescent health. Note: The deadline for advance registration has been extended to September 20. CDC's live two-day course Epidemiology & Prevention of Vaccine-Preventable Diseases is scheduled for October 29–30. The course provides a comprehensive review of immunizations and the diseases they prevent. Continuing education credits are available. Related Links
|
About IZ Express
IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde